Accuray Incorporated (ARAY) Q1 2027 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2027 Earnings Call Transcript
Seeking Alpha11/5/2026Neutral
ARAY
Accuray IncorporatedNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$13.22M
P/E Ratio
—
EPS
$-4.97
Beta
1.38
52W High
$1.21
52W Low
$0.11
50-Day MA
$0.21
200-Day MA
$0.35
Dividend Yield
—
Profit Margin
-12.20%
Forward P/E
94.34
PEG Ratio
29.49
About Accuray Incorporated
Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.
Fundamentals
| Revenue (TTM) | $401.95M |
| Gross Profit (TTM) | $111.45M |
| EBITDA | $-3.53M |
| Operating Margin | 6.21% |
| Return on Equity | -80.10% |
| Return on Assets | -1.40% |
| Revenue/Share (TTM) | $3.28 |
| Book Value | $0.35 |
| Price-to-Book | 0.28 |
| Price-to-Sales (TTM) | 0.03 |
| EV/Revenue | 0.275 |
| EV/EBITDA | 5.10 |
| Quarterly Earnings Growth (YoY) | -96.20% |
| Quarterly Revenue Growth (YoY) | -20.90% |
| Shares Outstanding | $120.20M |
| Float | $113.42M |
| % Insiders | 4.62% |
| % Institutions | 64.48% |
Historical Volatility
HV 10-Day
134.96%
HV 20-Day
109.99%
HV 30-Day
149.09%
HV 60-Day
115.49%
HV Rank
—
Volatility is currently contracting
Latest News
Accuray Announces 1-for-40 Reverse Stock Split
MADISON, Wis., Nov. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has approved a 1-for-40 reverse stock split of the Company's common stock and a corresponding decrease to the authorized number of shares of common stock.
PRNewsWire11/4/2026Neutral
Accuray Reports Fiscal 2027 First Quarter Financial Results
MADISON, Wis., Nov. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2026.
PRNewsWire11/4/2026Neutral
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., Oct. 30, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sofiane Laoussadi, the company's new Senior Vice President, Global Services & Solutions.
PRNewsWire10/30/2026Neutral
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
MADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by company management at 1:30 p.m.
PRNewsWire10/21/2026Neutral
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
MADISON, Wis., Oct. 6, 2026 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's primary lender and largest shareholder.
PRNewsWire10/6/2026Neutral
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.
PRNewsWire9/11/2026Neutral
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Seeking Alpha8/19/2026Neutral
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
MADISON, Wis., Aug. 19, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026.
PRNewsWire8/19/2026Neutral
Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments
MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth.
PRNewsWire8/12/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARAY and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 11/7/2026